BlastiMin Complex

BlastiMin Complex
Product Description

PRODUCT

Nutraceutical designed to support conventional therapies for osteoporosis treatment

The only clinicaly tested nutraceutical formulation with proven pro-osteogenic action

INNOVATIVE FEATURES

  • High bioavailability of the compounds present in the formulation;
  • Synergistic effects demonstrated on osteogenic markers (COL1A1 and ALP);
  • Clinical evidence of a statistically significant increase in the main osteogenic markers P1NP (*** p<0.001) and BTI (0.183 t12 vs 0.167 t0);
  • Clinical evidence of a decrease in the inflammatory marker CRP (*** p<0.001).

Read more Show less

Mivell Srl

  • Country/Region:
    Italy
  • On CPHI since:
    2025
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
OTC
Primary activities
Nutraceuticals
OTC
View company profile
Categories
more categories Show less
Specifications
  • Details
    Osteopenia and Osteoporosis
  • Selling Points
    Bone & Joint Health; Using delivery systems (which are safeguarded as an industrial trade secret), the bioavailability of the natural molecules in the formulation has been enhanced. The pharmaceutical form used promotes the intestinal absorption of the active ingredients.
More specifications Fewer specifications
Sales Markets
Show more Show less

Mivell Srl

  • Country/Region:
    Italy
  • On CPHI since:
    2025
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
OTC
Primary activities
Nutraceuticals
OTC
View company profile

Mivell Srl resources (1)